Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: McNeil

This article was originally published in The Tan Sheet

Executive Summary

McNeil: Publicizes National Kidney Foundation statement issued Nov. 3 at the group's 45th annual meeting in San Diego recommending acetaminophen for patients with kidney failure "because of the bleeding complications associated with aspirin." In a same-day release, McNeil quoted the group as saying that "NKF symposium participants expressed `serious concern' about the use of NSAIDs by `people who have underlying kidney disease, heart disease, severe high blood pressure, and by elderly people who are taking diuretics.'" NKF also expressed reservations about the use of OTC NSAIDs by athletes, according to McNeil. The foundation, McNeil said, recommended that "mixed analgesics" containing aspirin, acetaminophen and caffeine be removed from the market...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel